bellvei.cat

The CLIP1–LTK fusion is an oncogenic driver in non‐small‐cell lung

5 (489) · $ 21.00 · In stock

Combinatorial tumor suppressor inactivation efficiently initiates

Nature:非小细胞肺癌新靶点CLIP1-LTK被发现,劳拉替尼效果不错@MedSci

科学家揭示非小细胞肺癌新的驱动因素与药物靶点- 专区- 生物谷

Frontiers Recent progress in targeted therapy for non-small cell

The CLIP1-LTK fusion is an oncogenic driver in non-small-cell lung

Utility of needle biopsy in centrally located lung cancer for

IJMS, Free Full-Text

肺癌靶点研究渐露锋芒,源井生物基因编辑细胞助力肿瘤研究_源井生物

IJMS, Free Full-Text

The CLIP1-LTK fusion is an oncogenic driver in non-small-cell lung

CLIP1-LTK fusion: A novel druggable gene fusion in NSCLC

Genotype-phenotype mapping of a patient-derived lung cancer